X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/25/2817418/0/en/Titan-Pharmaceuticals-Fully-Compliant-With-NASDAQ-Listing-Criteria.html
https://www.globenewswire.com//news-release/2023/12/28/2801853/0/en/Titan-Pharmaceuticals-Announces-Reverse-Stock-Split-and-Ratio.html
https://www.globenewswire.com//news-release/2023/10/16/2761085/0/en/Titan-Pharmaceuticals-Announces-Appointment-of-Dato-Seow-Gim-Shen-and-Brynner-Chaim-to-the-Company-s-Board-of-Directors.html
https://www.globenewswire.com//news-release/2023/09/18/2744665/0/en/Titan-Pharmaceuticals-Announces-9-5-Million-Private-Placement-of-Convertible-Preferred-Stock.html
https://www.globenewswire.com/news-release/2023/07/27/2712070/0/en/Titan-Pharmaceuticals-Announces-Sale-of-Certain-ProNeura-Assets.html
https://www.globenewswire.com/news-release/2022/12/15/2574394/0/en/Titan-Pharmaceuticals-Provides-Shareholder-Update.html
https://www.globenewswire.com//news-release/2022/12/12/2571764/0/en/UPDATE-Titan-Pharmaceuticals-Inc-Announces-Licensing-Agreement-with-Ocular-Therapeutix-Inc.html
https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-board-expansion-and-management-changes-301606754.html
https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-fda-clearance-of-ind-application-for-nalmefene-implant-301580339.html
https://www.prnewswire.com/news-releases/titan-pharmaceuticals-announces-pricing-of-5-5-million-registered-direct-and-pipe-offering-priced-at-the-market-301473821.html
Market Place
Share 
